For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

The Trump administration has resumed collection efforts on student loans, affecting those in default sooner than expected.

The American Diabetes Association (ADA) now recommends GLP-1 agonists for overweight individuals ... Exenatide and exendin-4 showed similar benefits in animal studies, enhancing populations ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Businesses are struggling with the high cost of healthcare benefits ... disability and absence data can help employers understand ROI from a productivity perspective. Understanding the cost of GLP ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

"By quantifying both the health and economic benefits of GLP-1 access, this work not only advances the dialogue around obesity management in the U.S. workforce, it also paves the way for scalable ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...

Eli Lilly and Company (NYSE:LLY) announced today that its ACHIEVE-1 trial for the oral GLP-1 medication ... indicating potential for further benefits. Despite higher rates of gastrointestinal ...